Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masatoshi Ueda is active.

Publication


Featured researches published by Masatoshi Ueda.


Annals of Internal Medicine | 1973

Hyperamylasemia with Carcinoma of the Lung

R. W. Ammann; J. Edward Berk; Louis Fridhandler; Masatoshi Ueda; W. Wegmann

Abstract Two patients with pronounced hyperamylasemia and hyperamylasuria, associated with metastatic carcinoma of the lung, are described. The primary lung tumor in the one patient with tissue ava...


International Journal of Pancreatology | 1992

Histological pancreatitis in end-stage renal disease

Toshie Araki; Masatoshi Ueda; Katsuo Ogawa; Takao Tsuji

SummaryTo clarify a possible cause of hyperainylasemia in end-stage renal disease (ESRD), histological studies were performed on the pancreatic glands of twenty-seven autopsied patients with ESRD who had received long-term hemodialysis. The findings were compared with those in a similar number of age-matched control subiects. Histological evidence of pancreatitis was found in 51.9% of the ESRD patients as compared with 14.8% in the controls (p < 0.005). The pancreatitis was chronic in nature in 85.7% of the ESRD patients showing changes of pancreatitis. Secretin administration to an additional group of twelve patients with ESRD induced an elevation in the activities of both total and P-type serum amylase in only one patient. These findings suggest that although histological pancreatic alterations are common in patients with ESRD, they are probably not responsible for the P-type hyperamylasemia frequently found in such patients.


Clinica Chimica Acta | 1971

Ultracentrifugal characteristics of macroamylasemic serum

Masatoshi Ueda; J. Edward Berk; Louis Fridhandler; James Davis

Abstract Sedimentation coefficients of the amylases present in the sera of 22 patients with macroamylasemia were measured by means of sucrose density gradient ultracentrifugation using beef liver catalase (11.3 S) and the 7 S serum proteins as markers. The sedimentation coefficients of the macroamylases in 18 of the cases ranged from 7.7 S to 10.7 S; in four cases the activity peaks were too broad to assign a definite sedimentation coefficient. One exceptional case (Case 6) exhibited two peaks of amylase activity: one had a sedimentation coefficient greater than the 19 S serum proteins and the other a coefficient of 10.7 S. The normal-size amylase component seen on dextran gel filtration was no longer discernible after ultracentrifugation in eight of the cases. These observations, in contrast to those on the paper electrophoretic pattern of those sera, suggest that the macroamylase complexes in patients with macroamylasemia are not homogeneous. The observations also indicate that dextran gel filtration may lead to erroneous concepts regarding the component fractions of serum amylase and their molecular sizes because of interaction between amylase and dextran.


Digestive Diseases and Sciences | 1989

Pancreatic-type hyperamylasemia in end-stage renal disease.

Toshie Araki; Masatoshi Ueda; Kazuhisa Taketa; Kiyowo Kosaka

Pancreatic-type isoamylase (P-type) and salivary-type isoamylase (S-type) activities were determined by the wheat protein inhibitor method in 29 patients with end-stage renal disease and in 38 healthy volunteers. Serum levels of total amylase (322±43 units/liter) and P-type (212±39 units/liter) in ESRD were significantly higher than those of controls (total: 142±7 units/liter,P<0.01; P-type: 52±4 units/liter,P<0.01). There was no significant difference between S-type activities in ESRD (110±16 units/liter) and in controls (90±6 units/liter). The ratios of amylase clearance to creatinine clearance (Cam/Ccr) and S-type clearance to creatinine clearance (Cs-amy/Ccr) rose significantly in ESRD(Cam/Ccr: 5.7±0.6%; Cs-amy/Ccr: 4.3±0.55%) compared to controls (Cam/Ccr: 3.2±0.24%,P<0.01; Cs-amy/Ccr: 2.1±0.17%,P<0.01). The ratio of P-type clearance to creatinine clearance (Cp-amy/Ccr) revealed no significant difference between ESRD (5.5±0.54%) and controls (5.6±0.42%). The renal excretion of P-type appeared to be more impaired than that of S-type in ESRD.


Journal of Gastroenterology | 1994

Age and sex-dependent alterations of serum amylase and isoamylase levels in normal human adults

Masatoshi Ueda; Toshie Araki; Tetsuya Shiota; Kazuhisa Taketa

Total amylase and salivary-and pancreatic-type isoamylase levels were assayed in sera from 606 apparently healthy adults of different sex and age groups. There were significant differences in both total amylase and isoamylase levels, depending on age and sex, one of the characteristics being that levels of these three enzymes were significantly higher in the elderly group in both men and women than in other age groups. Another feature was that all of these enzyme levels were significantly greater in women in the third and fourth decade than in men. Age and sex differences should be taken into consideration in the evaluation of mild hyperamylasemia.


Experimental Biology and Medicine | 1971

Macroamylasemia: Variation in the Response of the Macroamylase Complex to Acidification

Masatoshi Ueda; J. Edward Berk; Louis Fridhandler

Summary Acidification had a variable effect on the integrity of the large amylase component in the sera of 21 patients with macro-amylasemia. Reduction of pH to 3.4 resulted in complete dissociation of the macroamylase in 13 cases; partial dissociation occurred in six while two remained unchanged. The response to acidification could be correlated with the sedimentation coefficients of the complexes: macroamylases with the highest coefficients tended not to be affected by acidification; those with the lowest values tended to be completely dissociated, while those with intermediate values tended to be partially dissociated. The variable response to lowering of the pH provides further evidence pointing to heterogeneity of the macroamylase complexes.


Clinical Chemistry | 1972

Isolation and Measurement of Pancreatic Amylase in Human Serum and Urine

Louis Fridhandler; J. Edward Berk; Masatoshi Ueda


Clinical Chemistry | 1971

Macroamylasemia: Rapid Detection Method

Louis Fridhandler; J. Edward Berk; Masatoshi Ueda


Cancer Research | 1988

Profiles of Carbohydrate-metabolizing Enzymes in Human Hepatocellular Carcinomas and Preneoplastic Livers

Kazuhisa Taketa; Junnosuke Shimamura; Masatoshi Ueda; Yoshihiro Shimada; Kiyowo Kosaka


Clinica Chimica Acta | 1995

Preferential salivary-type hypoamylasemia in obesity

Kazuhisa Taketa; Masatoshi Ueda; Kiyowo Kosaka

Collaboration


Dive into the Masatoshi Ueda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Edward Berk

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James Davis

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge